Guanidine degradation enzyme and methods of use
View Patent ↗Presented herein are Synechococcus strains engineered to express the bacterial ethylene-forming enzyme (EFE) that exhibit unstable ethylene production due to toxicity and genomic instability induced by accumulation of the EFE-byproduct guanidine. Co-expression of EFE and Sll1077 significantly enhanced genomic stability and enabled the resulting Synechococcus strain GD-EFE7942 to achieve sustained high-level ethylene production. The engineered strains and methods disclosed herein are useful for guanidine degradation pathways and for ethylene bioproduction in cyanobacteria.
1. A non-naturally occurring Synechocystis or Synechococcus cyanobacterial strain engineered to express a heterologous bacterial ethylene-forming enzyme (EFE) and a guanidine degradation enzyme.
2. The non-naturally occurring cyanobacterial strain of claim 1 wherein the guanidine degradation enzyme is encoded by sll1077.
3. The non-naturally occurring cyanobacterial strain of claim 1 comprising improved cell growth in a solution containing guanidine compared to a naturally occurring cyanobacterial strain.
4. The non-naturally occurring cyanobacterial strain of claim 1 wherein the cyanobacterial strain is selected from the group consisting of Synechocystis PB816H, Synechocystis PB817H and Synechococcus elongatus GD.
5. The non-naturally occurring cyanobacterial strain of claim 1 wherein the strain is capable of ethylene production.
6. The non-naturally occurring cyanobacterial strain of claim 1 wherein the strain is capable of guanidine degradation.
7. A method for guanidine degradation comprising the step of exposing the non-naturally occurring cyanobacterial strain of claim 1 to a solution containing guanidine.